Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children. [electronic resource]
Producer: 20190705Description: 188-200 p. digitalISSN:- 1532-6535
- Acetates -- metabolism
- Analgesics, Opioid -- metabolism
- Anti-Asthmatic Agents -- metabolism
- Anti-Inflammatory Agents, Non-Steroidal -- metabolism
- Antifungal Agents -- metabolism
- Bronchodilator Agents -- metabolism
- Child
- Child, Preschool
- Cyclopropanes
- Cytochrome P-450 CYP1A2 -- metabolism
- Cytochrome P-450 CYP2C19 -- metabolism
- Cytochrome P-450 CYP2C8 -- metabolism
- Cytochrome P-450 CYP2C9 -- metabolism
- Cytochrome P-450 CYP2D6 -- metabolism
- Cytochrome P-450 CYP3A -- metabolism
- Cytochrome P-450 Enzyme System -- metabolism
- Diclofenac -- metabolism
- Esomeprazole -- metabolism
- Histamine H1 Antagonists, Non-Sedating -- metabolism
- Humans
- Infant
- Infant, Newborn
- Itraconazole -- metabolism
- Lansoprazole -- metabolism
- Loratadine -- analogs & derivatives
- Models, Biological
- Ondansetron -- metabolism
- Pharmaceutical Preparations -- metabolism
- Pharmacokinetics
- Proton Pump Inhibitors -- metabolism
- Quinolines -- metabolism
- Serotonin Antagonists -- metabolism
- Sufentanil -- metabolism
- Sulfides
- Theophylline -- metabolism
- Tramadol -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.